Press

LATEST NEWS

Gedeon Richter and Myovant Sciences Enter into Exclusive License Agreement to Commercialize Relugolix Combination Tablet for Uterine Fibroids and Endometriosis in Certain Territories Outside the U.S.
By amarone in News, Press Releases on March 31, 2020
31 March 2020 Budapest, Hungary and Basel, Switzerland – Myovant Sciences (NYSE:MYOV), a healthcare company focused on developing innovative…
Read more
0
Richter announces the acquisition of Finox Holding
By Irene Tamayo in News, Press Releases on June 30, 2016
30 June 2016 Richter announces the acquisition of Finox Holding for a consideration of CHF190 million. Finox Holding, a…
Read more
0

Efficacy and Safety of repeated use of ulipristal acetate in uterine fibroids
By Irene Tamayo in Publication on February 15, 2015
Authors: Jacques Donnez, Robert Hudecek, Olivier Donnez, Dace Matule, Hans-Joachim Ahrendt, Janos Zatik, Zaneta Kasilovskiene, Mihai Cristian Dumitrascu, Hervé Fernandez,…
Fertility and Sterility® Vol. 103, No. 2, February 2015 0015-0282
0
Long-term treatment of uterine fibroids with ulipristal acetate
By Irene Tamayo in Publication on June 15, 2014
Authors: Donnez J, Vazquez F, Tomaszewski J, Nouri K, Bouchard P, Fauser BC et al. quickbooks customer care phone…
Fertil Steril 2014;101(6):1565-73
0

A career at Preglem® is more than just a job. It gives you the opportunity to solve challenging global problems in a way that can change the world.

In line with our corporate culture, we treat all information received with full confidentiality.